FRANCISCI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 9.801
EU - Europa 7.619
AS - Asia 6.612
SA - Sud America 1.414
AF - Africa 130
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 14
Totale 25.604
Nazione #
US - Stati Uniti d'America 9.592
SG - Singapore 3.190
IE - Irlanda 1.482
IT - Italia 1.275
BR - Brasile 1.196
HK - Hong Kong 1.067
UA - Ucraina 1.042
SE - Svezia 970
CN - Cina 934
RU - Federazione Russa 927
VN - Vietnam 625
DE - Germania 523
FI - Finlandia 382
KR - Corea 296
GB - Regno Unito 278
FR - Francia 185
AT - Austria 129
CA - Canada 109
PL - Polonia 86
AR - Argentina 84
TR - Turchia 84
IN - India 66
MX - Messico 62
BD - Bangladesh 60
NL - Olanda 56
BE - Belgio 48
CH - Svizzera 48
JP - Giappone 48
ES - Italia 46
ID - Indonesia 46
ZA - Sudafrica 43
UZ - Uzbekistan 40
EE - Estonia 36
EC - Ecuador 32
IQ - Iraq 29
VE - Venezuela 25
CZ - Repubblica Ceca 22
PY - Paraguay 20
CO - Colombia 17
LT - Lituania 17
AE - Emirati Arabi Uniti 14
CL - Cile 14
PK - Pakistan 14
EG - Egitto 13
GR - Grecia 13
EU - Europa 12
MA - Marocco 12
AU - Australia 11
KE - Kenya 11
RO - Romania 11
IR - Iran 10
LB - Libano 10
SA - Arabia Saudita 10
IL - Israele 9
BO - Bolivia 8
DZ - Algeria 8
PE - Perù 8
AZ - Azerbaigian 7
JO - Giordania 7
NP - Nepal 7
PA - Panama 7
TN - Tunisia 7
UY - Uruguay 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
HR - Croazia 5
NG - Nigeria 5
PH - Filippine 5
HN - Honduras 4
JM - Giamaica 4
NI - Nicaragua 4
NO - Norvegia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
GA - Gabon 3
KW - Kuwait 3
MG - Madagascar 3
TT - Trinidad e Tobago 3
AD - Andorra 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
CY - Cipro 2
DJ - Gibuti 2
DK - Danimarca 2
GY - Guiana 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
LY - Libia 2
MK - Macedonia 2
MU - Mauritius 2
MY - Malesia 2
QA - Qatar 2
Totale 25.558
Città #
Singapore 1.990
Dublin 1.478
Chandler 1.305
Hong Kong 1.062
San Mateo 755
Boardman 566
Jacksonville 496
Santa Clara 466
Ashburn 438
Perugia 423
Altamura 415
Medford 381
Princeton 380
Dong Ket 321
Lawrence 304
Seoul 294
Moscow 291
Wilmington 277
Ann Arbor 254
Andover 231
Los Angeles 186
Beijing 167
Columbus 156
Munich 141
Des Moines 138
New York 133
Piscataway 126
Ho Chi Minh City 120
São Paulo 112
Saint Petersburg 97
Dearborn 93
The Dalles 82
Norwalk 77
Redmond 77
Helsinki 73
Woodbridge 73
Falls Church 69
Nuremberg 68
Hanoi 59
San Paolo di Civitate 58
Shanghai 50
Vienna 50
Houston 49
Brussels 46
Turku 46
Rome 45
Izmir 44
Dallas 43
Warsaw 43
Tokyo 42
Montreal 41
Chicago 37
London 35
Rio de Janeiro 34
Hefei 33
Brooklyn 31
Frankfurt am Main 30
San Francisco 30
Boston 28
Johannesburg 28
Philadelphia 26
Redwood City 26
Den Haag 25
Stockholm 25
Brasília 24
Denver 24
Phoenix 24
Poplar 24
Amsterdam 23
Mexico City 23
Toronto 23
Belo Horizonte 22
Chennai 22
Ankara 21
Falkenstein 21
Orem 19
Porto Alegre 19
Manchester 18
Florence 17
Ottawa 17
Seattle 17
Bologna 16
Campinas 16
Curitiba 16
Frankfurt Am Main 16
Guangzhou 16
Atlanta 15
Auburn Hills 15
Lappeenranta 15
Milan 15
Padova 15
Fortaleza 14
Tashkent 14
Da Nang 13
Dhaka 12
Guarulhos 12
Haiphong 12
Mumbai 12
Nanjing 12
San Diego 12
Totale 15.745
Nome #
Amfotericina B in complessi lipidici nel trattamento della Leishmaniosi viscerale in un paziente immunodepresso 139
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione 130
Concentrazioni ossee e plasmatiche di moxifloxacina in pazienti operati di protesi di ginocchio 129
Diagnosis of central nervous system herpes virus infections by a single multiplex PCR. 11th European Congress of Clinical Microbiology and Infectious Diseases 126
A case of severe cdfepime-related neutropenia in a 15-year-old patient 126
A case of Propionibacterium acnes meningitis: additional evidence for anaerobes in neurosurgical infections 125
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 121
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 119
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 118
Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience 117
Acute fatal necrotizing hemorrhagic encephalitis caused by Epstein-Barr virus in a young adult immunocompetent man 114
Acute cytomegalovirus meningomyelitis in an immunocompetent patient. 112
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 112
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 112
Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study 111
Anal Cancer Screening for Diagnosis and Treatment of Anal Squamous Intraepithelial Lesions in HIV-positive MSM patients 110
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 109
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 109
Esperienza con Efavirenz nei pazienti con infezione da HIV seguiti presso la Clinica di Malattie Infettive di Perugia 108
Mielite da Toxoplasma gondii in un paziente con AIDS 108
Bone and serum concentrations of moxifloxacin in patients undergoing total knee arthroplasty 108
Nocardiosi cerebrale primaria in un paziente immunocompetente 107
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI 107
A randomized trial comparing the introduction of ritonavir on indinavir in 1251 nucleoside-experienced patients with advanced HIV infection 106
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 106
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 103
Prima indagine sieroepidemiologica sulla circolazione del virus Toscana in Umbria. Atti congresso di malattie Infettive 102
Epidemiological, clinical and therapeutical aspects of HIV/HCV coinfection in a series of HIV seropositive Umbrian patients. 102
L'infezione da Clostridium Difficile in pazienti ospedalizzati: uno studio retrospettivo. XXIX Congresso AMCLI 2000, 101
Trattamento dell'epatite cronica C con IFN-2b e ribavirina in pazienti non responder o relapser a solo IFN-: dati preliminari sulla nostra esperienza. 100
Acute appendicitis due to Cytomegalovirus in an apparently immunocompetent patient: a case report 100
Impact of Antimicrobial Stewardship Interventions on Appropriateness of Surgical Antibiotic Prophylaxis: How to Improve 100
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 99
A case of rhombencephalitis caused by Listeria monocytogenes successfully treated with linezolid 98
Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors. 98
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 98
Malattie Infettive trasmesse da Zecca in Umbria: indagine epidemiologica 97
Benefits of a rapid HIV test for evaluation of the source patient after occupational exposure of healthcare workers. 97
Daily bathing with 4% chlorhexidine gluconate in intensive care settings: a randomized controlled trial 97
Acute infection with parvovirus B19 manifesting as brain stem encephalitis. 97
Alterazioni in HCMV end-organ disease in the course of highly active antiretroviral therapy (HAART). 97
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 96
Target di autoimmunità endocrina in corso di terapia con IFN-alfa in pazienti con epatite cronica da HCV. 30°congr.naz. SISMIP, Ferrara 6-9 ottobre 1999 95
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2 94
Modificazioni epidemiologiche delle epatiti virali acute in Umbria; 30 anni di osservazione. Congresso Soc. It. Mal. Inf. 94
ANALISI DELLA FUNZIONALITÀ RENALE IN PAZIENTI CON INFEZIONE DA HIV NAIVE TRATTATI CON TENOFOVIR. STUDIO CASO-CONTROLLO. 94
Risk factors for acute parenterally transmitted viral hepatitis: a 20-year study. 94
Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty 94
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 94
Long term treatment of a variant form of autoimmune chronic active hepatitis with cyclosporine: a case report. 94
Tolerability of different postexposure prophylaxis regimens in occupational and non occupational exposures to HIV: the italian registry 93
Encefalite emorragica e infezione disseminata da Epstein barr virus: descrizione di un caso clinico con outcome fatale. 93
Partial achievement of the 90-90-90 UNAIDS target in a cohort of HIV infected patients from Central Italy 93
Fatal Haemolytic Uraemic Syndrome in an AIDS patient with disseminated Adenovirus and Cytomegalovirus co-infection. 92
Patologie neurologiche AIDS-defining in era HAART e Pre-HAART: nuovi scenari 91
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 91
Combined ganciclovir and foscarnet therapy of recurrent cytomegalovirus and aggressive retinitis in AIDS 91
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light 91
Epidemiologia, clinica e terapia della coinfezione HIV-HCV nell'esperienza umbra. 90
Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. 90
A nutraceutical combination targeting dyslipidemia and subclinical inflammation in HIV patients on stable antiretroviral therapy 90
Metodo rapido di estrazione dell'RNA da C. neoformans. 89
Effects of antiretroviral therapy on lipid and immunovirological profile: Focus on proprotein convertase subtilisin/kexin 9 89
epidemiologia e clinica della coinfezione HIV-HCV nell'esperienza umbra 88
Malattie da virus a DNA- Citomegalovirosi 88
Tipranavir exhibits different effects on opportunistic pathogenic fungi. 88
Tuberculosis After Gastrectomy, Plasmatic Concentration of Antitubercular Drugs 88
Programmed granulocyte neutrophil death in patients at different stages of HIV infection 87
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease. 87
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 87
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. 86
In vitro antibacterial activity of ceftazidime/avibactam in combination against planktonic and biofilm carbapenemase-producing Klebsiella pneumoniae isolated from blood 86
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. 86
Acute transverse myelitis and hepatitis C virus 85
Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS 84
Biochemical markers of bone turnover and calcium dietary intake evaluation in HIV-infected patients 84
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 83
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia A Randomized Clinical Trial 83
La terapia HAART nell'esperienza della clinica di Malattie Infettive di Perugia 82
Semiquantitative PCR in the diagnosis of HIV infection: correlation to clinical stage and serological status. 82
Correlation of preS antigens and clinical status during chronic hepatitis B virus infection. 82
Hepatitis C virus genotypes in the liver and serum of patients with chronic hepatitis C 82
Thyroid function tests in acute viral hepatitis:relative reduction in serum thyroxine levelsdue to T4-TBG binding inhibitors in patients with severe liver cell necrosis 82
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 82
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 81
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study 81
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 81
A proposal for a comprehensive approach to infections across the surgical pathway 81
Identificazione dei soggetti a più alto rischio di infezione disseminata da HCMV tra i riceventi un trapianto renale. 30° congr.naz. SISMIP Ferrara 6-9 ottobre 1999 80
Cytomegalovirus colitis in a patient with recent failure of kidney transplant. 80
Monocyte dysfunction in patients with acquired immunodeficiency syndrome (AIDS) versus Cryptococcus neoformans 80
Efficacy of Maraviroc (MVC) as intensification strategy in immunological non-responder(INR) HIV-1-infected patients treated with HAART 80
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression 79
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 79
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 79
Seroprevalence of anti-SARS-CoV2 antibodies in umbrian persons living with HIV 79
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality 79
Suboptimal indinavir concentrations in cerebrospinal fluid 78
Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy. 78
Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline 78
Totale 9.562
Categoria #
all - tutte 133.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.397 0 0 0 0 0 184 160 41 290 135 192 395
2021/20223.052 98 531 84 184 109 55 48 912 70 106 387 468
2022/20235.045 429 995 76 384 365 495 25 202 1.839 6 171 58
2023/20241.835 106 208 91 41 16 16 417 32 212 74 342 280
2024/20255.613 50 548 130 167 705 230 332 365 1.352 372 747 615
2025/20265.843 848 774 789 1.602 1.475 355 0 0 0 0 0 0
Totale 26.675